Health 2.0 is just getting into the mainstream. Other tools and approaches like disease management and patient safety seem to have been held back because they can’t prove the elusive ROI. Others, like EMRs & ACOs and almost any med tech intervention and drug you can think of seem to roll right ahead. Thus, how should we think about the business future and likely impact of the technologies we show on stage? What should we all be saying to the health care system? Patient safety expert and all around witty gadfly Michael Millenson joins Matthew Holt to make some suggestions.